论文信息 - Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial. - 字舞流文

Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial.

P. Morlat | C. Rouzioux | L. Meyer | K. Lacombe | C. Goujard | A. Chéret | J. Reynes | V. Avettand-Fenoel | S. Abel | F. Ajana | V. Meiffrédy | R. Calin | C. Lascoux | Rebecca Bauer | Pauline Lopez